Shi YK - Search Results

1

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.

Vitolo U, Trněný M, Belada D, Burke JM, Carella AM, Chua N, Abrisqueta P, Demeter J, Flinn I, Hong X, Kim WS, Pinto A, Shi YK, Tatsumi Y, Oestergaard MZ, Wenger M, Fingerle-Rowson G, Catalani O, Nielsen T, Martelli M, Sehn LH. Vitolo U, et al. Among authors: shi yk. J Clin Oncol. 2017 Nov 1;35(31):3529-3537. doi: 10.1200/JCO.2017.73.3402. Epub 2017 Aug 10. J Clin Oncol. 2017. PMID: 28796588 Clinical Trial.

2

[Clinical and pathological analysis of 15 cases with primary breast lymphoma].

Huang DZ, He XH, Yang S, Shi YK. Huang DZ, et al. Among authors: shi yk. Ai Zheng. 2004 Aug;23(8):939-42. Ai Zheng. 2004. PMID: 15301719 Chinese.

3

[Primary central nervous system lymphoma: a report of 28 patients].

Hu Y, Feng FY, Shi YK, Zhou LQ, Gu DZ, Wang QL. Hu Y, et al. Among authors: shi yk. Zhonghua Zhong Liu Za Zhi. 2004 Jun;26(6):375-8. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312352 Chinese.

4

[Clinicopathologic features of primary thyroid lymphoma].

Zhou SY, Huang DZ, Shi YK, He XH, Wu YH, Li YX. Zhou SY, et al. Among authors: shi yk. Ai Zheng. 2005 Jan;24(1):95-8. Ai Zheng. 2005. PMID: 15642210 Chinese.

5

[Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].

Lin TY, Zhang HY, Huang Y, Guan ZZ, Shen T, Shi YK, Zhu J, Ke XY, Wang HQ, Shen ZX, Yu SY, Liu T, Shi XL. Lin TY, et al. Among authors: shi xl, shi yk. Ai Zheng. 2005 Dec;24(12):1421-6. Ai Zheng. 2005. PMID: 16351785 Clinical Trial. Chinese.

6

[Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].

Qin Y, Shi YK, He XH, Yang JL, Yang S, Yu YX, Li B, Wang QL, Zhou LQ, Sun Y. Qin Y, et al. Among authors: shi yk. Ai Zheng. 2006 Apr;25(4):481-5. Ai Zheng. 2006. PMID: 16613685 Chinese.

7

[Monoclonal antibodies in the treatment of malignant lymphoma].

Niu Y, Shi YK. Niu Y, et al. Among authors: shi yk. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Jun;28(3):435-41. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006. PMID: 16900652 Review. Chinese.

8

[Efficacy of modified Hyper-CVAD regimen on non-Hodgkin's lymphoma and safety evaluation].

Shi W, Shi YK, He XH, Yang JL, Zhang CG, Zhou SY, Dong M, Liu P, Qin Y, Yang S, Gui L, Lv Z. Shi W, et al. Among authors: shi yk. Ai Zheng. 2009 Oct;28(10):1083-7. doi: 10.5732/cjc.009.10044. Ai Zheng. 2009. PMID: 19799818 Free article. Chinese.

9

[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].

Qin Y, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang JL, Yang S, Zhang CG, Dong M, Zhou LQ, Wang JW, Feng FY, Sun Y. Qin Y, et al. Among authors: shi yk. Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):469-73. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950562 Chinese.

10

[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].

Shi YK, Yang S, Han XH, Ma J, Ren HY, Cen XN, Zhou SY, Wang C, Jiang WQ, Huang HQ, Wang JM, Zhu J, Chen H, Han MZ, Huang H, Shen XM, Liu P, He XH. Shi YK, et al. Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):592-6. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20021946 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page